Exploring the effect of intracellular loop 1 genetic variants in human ABCG2 on transport activity and protein abundance

ABCG2 (breast cancer resistance protein, BCRP), can affect drug disposition, and thus, variation in the ABCG2 gene may alter drug exposure. We studied non-synonymous naturally occurring single-nucleotide variants (SNVs) in intracellular loop 1 (ICL1), which contains a coupling helix that transmits c...

Full description

Saved in:
Bibliographic Details
Published inDrug metabolism and pharmacokinetics Vol. 62; p. 101482
Main Authors Sjöstedt, Noora, Timmermans, Ritchie G.M., Vieraankivi, Marika, Suominen, Laura, Vellonen, Kati-Sisko, Bhattacharya, Madhushree, Auriola, Seppo, Kidron, Heidi
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.06.2025
Subjects
Online AccessGet full text
ISSN1347-4367
1880-0920
1880-0920
DOI10.1016/j.dmpk.2025.101482

Cover

Loading…
Abstract ABCG2 (breast cancer resistance protein, BCRP), can affect drug disposition, and thus, variation in the ABCG2 gene may alter drug exposure. We studied non-synonymous naturally occurring single-nucleotide variants (SNVs) in intracellular loop 1 (ICL1), which contains a coupling helix that transmits conformational changes in the protein. Reference ABCG2, the common SNVs V12M and Q141K, and five SNVs (K453R, I456V, H457R, G462R and G462V) in ICL1 were expressed in HEK293 cells. Additionally, combinations of selected SNVs were expressed to determine if an activating substitution in ICL1 could compensate for an inactivating substitution elsewhere. Transport of Lucifer yellow, estrone sulfate and rosuvastatin was studied using membrane vesicles and the ABCG2 abundance was quantified. While K453R and I456V abundance was similar to the reference ABCG2, abundance was lower for H457R and G462R/V. Apparent transport activities were partially substrate dependent, but excluding G462R/V, the ICL variants transported at least one of the substrates similarly to the reference ABCG2. In double substitutions, I456V had a more consistent effect than H457R on both transport activity and protein abundance. Altogether, SNVs in ICL1 can have both detrimental and beneficial effects on ABCG2 activity. Effects may be hard to predict, especially if more than one SNV is present. [Display omitted]
AbstractList ABCG2 (breast cancer resistance protein, BCRP), can affect drug disposition, and thus, variation in the ABCG2 gene may alter drug exposure. We studied non-synonymous naturally occurring single-nucleotide variants (SNVs) in intracellular loop 1 (ICL1), which contains a coupling helix that transmits conformational changes in the protein. Reference ABCG2, the common SNVs V12M and Q141K, and five SNVs (K453R, I456V, H457R, G462R and G462V) in ICL1 were expressed in HEK293 cells. Additionally, combinations of selected SNVs were expressed to determine if an activating substitution in ICL1 could compensate for an inactivating substitution elsewhere. Transport of Lucifer yellow, estrone sulfate and rosuvastatin was studied using membrane vesicles and the ABCG2 abundance was quantified. While K453R and I456V abundance was similar to the reference ABCG2, abundance was lower for H457R and G462R/V. Apparent transport activities were partially substrate dependent, but excluding G462R/V, the ICL variants transported at least one of the substrates similarly to the reference ABCG2. In double substitutions, I456V had a more consistent effect than H457R on both transport activity and protein abundance. Altogether, SNVs in ICL1 can have both detrimental and beneficial effects on ABCG2 activity. Effects may be hard to predict, especially if more than one SNV is present. [Display omitted]
ABCG2 (breast cancer resistance protein, BCRP), can affect drug disposition, and thus, variation in the ABCG2 gene may alter drug exposure. We studied non-synonymous naturally occurring single-nucleotide variants (SNVs) in intracellular loop 1 (ICL1), which contains a coupling helix that transmits conformational changes in the protein. Reference ABCG2, the common SNVs V12M and Q141K, and five SNVs (K453R, I456V, H457R, G462R and G462V) in ICL1 were expressed in HEK293 cells. Additionally, combinations of selected SNVs were expressed to determine if an activating substitution in ICL1 could compensate for an inactivating substitution elsewhere. Transport of Lucifer yellow, estrone sulfate and rosuvastatin was studied using membrane vesicles and the ABCG2 abundance was quantified. While K453R and I456V abundance was similar to the reference ABCG2, abundance was lower for H457R and G462R/V. Apparent transport activities were partially substrate dependent, but excluding G462R/V, the ICL variants transported at least one of the substrates similarly to the reference ABCG2. In double substitutions, I456V had a more consistent effect than H457R on both transport activity and protein abundance. Altogether, SNVs in ICL1 can have both detrimental and beneficial effects on ABCG2 activity. Effects may be hard to predict, especially if more than one SNV is present.
ABCG2 (breast cancer resistance protein, BCRP), can affect drug disposition, and thus, variation in the ABCG2 gene may alter drug exposure. We studied non-synonymous naturally occurring single-nucleotide variants (SNVs) in intracellular loop 1 (ICL1), which contains a coupling helix that transmits conformational changes in the protein. Reference ABCG2, the common SNVs V12M and Q141K, and five SNVs (K453R, I456V, H457R, G462R and G462V) in ICL1 were expressed in HEK293 cells. Additionally, combinations of selected SNVs were expressed to determine if an activating substitution in ICL1 could compensate for an inactivating substitution elsewhere. Transport of Lucifer yellow, estrone sulfate and rosuvastatin was studied using membrane vesicles and the ABCG2 abundance was quantified. While K453R and I456V abundance was similar to the reference ABCG2, abundance was lower for H457R and G462R/V. Apparent transport activities were partially substrate dependent, but excluding G462R/V, the ICL variants transported at least one of the substrates similarly to the reference ABCG2. In double substitutions, I456V had a more consistent effect than H457R on both transport activity and protein abundance. Altogether, SNVs in ICL1 can have both detrimental and beneficial effects on ABCG2 activity. Effects may be hard to predict, especially if more than one SNV is present.ABCG2 (breast cancer resistance protein, BCRP), can affect drug disposition, and thus, variation in the ABCG2 gene may alter drug exposure. We studied non-synonymous naturally occurring single-nucleotide variants (SNVs) in intracellular loop 1 (ICL1), which contains a coupling helix that transmits conformational changes in the protein. Reference ABCG2, the common SNVs V12M and Q141K, and five SNVs (K453R, I456V, H457R, G462R and G462V) in ICL1 were expressed in HEK293 cells. Additionally, combinations of selected SNVs were expressed to determine if an activating substitution in ICL1 could compensate for an inactivating substitution elsewhere. Transport of Lucifer yellow, estrone sulfate and rosuvastatin was studied using membrane vesicles and the ABCG2 abundance was quantified. While K453R and I456V abundance was similar to the reference ABCG2, abundance was lower for H457R and G462R/V. Apparent transport activities were partially substrate dependent, but excluding G462R/V, the ICL variants transported at least one of the substrates similarly to the reference ABCG2. In double substitutions, I456V had a more consistent effect than H457R on both transport activity and protein abundance. Altogether, SNVs in ICL1 can have both detrimental and beneficial effects on ABCG2 activity. Effects may be hard to predict, especially if more than one SNV is present.
ArticleNumber 101482
Author Auriola, Seppo
Bhattacharya, Madhushree
Suominen, Laura
Kidron, Heidi
Timmermans, Ritchie G.M.
Sjöstedt, Noora
Vellonen, Kati-Sisko
Vieraankivi, Marika
Author_xml – sequence: 1
  givenname: Noora
  orcidid: 0000-0001-6960-7757
  surname: Sjöstedt
  fullname: Sjöstedt, Noora
  organization: Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland
– sequence: 2
  givenname: Ritchie G.M.
  surname: Timmermans
  fullname: Timmermans, Ritchie G.M.
  organization: Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland
– sequence: 3
  givenname: Marika
  surname: Vieraankivi
  fullname: Vieraankivi, Marika
  organization: Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland
– sequence: 4
  givenname: Laura
  orcidid: 0000-0003-1163-0182
  surname: Suominen
  fullname: Suominen, Laura
  organization: Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland
– sequence: 5
  givenname: Kati-Sisko
  orcidid: 0000-0002-3225-9186
  surname: Vellonen
  fullname: Vellonen, Kati-Sisko
  organization: School of Pharmacy, University of Eastern Finland, Kuopio, Finland
– sequence: 6
  givenname: Madhushree
  surname: Bhattacharya
  fullname: Bhattacharya, Madhushree
  organization: Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland
– sequence: 7
  givenname: Seppo
  surname: Auriola
  fullname: Auriola, Seppo
  organization: School of Pharmacy, University of Eastern Finland, Kuopio, Finland
– sequence: 8
  givenname: Heidi
  surname: Kidron
  fullname: Kidron, Heidi
  email: heidi.kidron@helsinki.fi
  organization: Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40203631$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1vFSEYhYmpsR_6B1wYlm7mytd8kLipN7WaNHGja8LAS8t1BkZgbtp_Xya3unTDS8hz3nDOuURnIQZA6D0lO0po9-mws_Pye8cIa7cHMbBX6IIOA2mIZOSs3rnoG8G7_hxd5nwghPNWsDfoXBBGeMfpBXq8eVymmHy4x-UBMDgHpuDosA8laQPTtE464SnGBVN8DwGKN_iok9eh5Erhh3XWAV9_2d8yHAOuqpCXmArWpvijL09YB4uXFAtUWo9rsDoYeIteOz1lePcyr9Cvrzc_99-aux-33_fXd40RVJZGAgfZmraaEwy46clIpeisAWetI72zdOhHA9TZjnE29nyQA6ln2_aStsCv0MfT3vqDPyvkomafN186QFyz4jUwwXopZUU_vKDrOINVS_KzTk_qb1oVYCfApJhzAvcPoURtlaiD2ipRWyXqVEkVfT6JoLo8ekgqGw81AetTzVrZ6P8nfwZX75RE
Cites_doi 10.1007/s00441-012-1417-5
10.1042/BCJ20170923
10.1007/s11095-017-2127-1
10.1007/s11095-021-03107-8
10.1016/j.xphs.2021.08.013
10.1002/jps.24366
10.1093/nar/gkz836
10.1038/s41586-018-0680-3
10.1111/j.1464-410X.2008.07913.x
10.1038/clpt.2013.12
10.1007/s00280-004-0931-x
10.2133/dmpk.22.428
10.1186/2045-8118-10-21
10.1093/nar/gks539
10.1002/jps.23436
10.1136/rmdopen-2017-000464
10.1002/ijc.11669
10.1023/B:PHAM.0000045245.21637.d4
10.1002/cpt.362
10.1124/jpet.109.163493
10.1124/dmd.118.083030
10.1073/pnas.1214530110
10.1186/s40246-018-0157-3
10.1038/clpt.2009.197
10.1038/s41598-017-11794-w
10.1124/dmd.114.062174
10.1208/s12248-014-9668-6
10.1038/sj.bjp.0706904
10.1124/jpet.115.225045
10.1038/nmeth0410-248
10.1124/dmd.117.079228
10.1007/s11095-008-9752-7
10.1038/nature22345
ContentType Journal Article
Copyright 2025 The Japanese Society for the Study of Xenobiotics
Copyright © 2025 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.
Copyright_xml – notice: 2025 The Japanese Society for the Study of Xenobiotics
– notice: Copyright © 2025 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.dmpk.2025.101482
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1880-0920
ExternalDocumentID 40203631
10_1016_j_dmpk_2025_101482
S134743672500432X
Genre Journal Article
GroupedDBID ---
--M
0R~
29G
2WC
4.4
457
53G
5GY
6I.
7-5
8P~
AAEDT
AAEDW
AAFTH
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AATTM
AAXKI
AAXUO
AAYWO
ABJNI
ABMAC
ABXDB
ACDAQ
ACGFO
ACGFS
ACRLP
ACVFH
ADBBV
ADCNI
ADEZE
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AFJKZ
AFPUW
AFTJW
AFXIZ
AGCQF
AGHFR
AGUBO
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
APXCP
AXJTR
BAWUL
BKOJK
BKOMP
BLXMC
CS3
DIK
DU5
E3Z
EBS
EFJIC
EFKBS
EJD
F5P
FDB
FEDTE
FIRID
FYGXN
GBLVA
GX1
HH5
HVGLF
HZ~
JMI
JSF
JSH
KOM
KQ8
M41
MOJWN
O9-
OAUVE
OVT
RJT
RNS
ROL
RZJ
SPCBC
SSP
SSZ
T5K
TKC
TR2
~G-
AAYXX
AGRNS
BNPGV
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
SSH
7X8
ID FETCH-LOGICAL-c419t-9e3e95c548242e3c70b1946dcefddf07fd187bce1fd6232b738980738557915e3
IEDL.DBID AIKHN
ISSN 1347-4367
1880-0920
IngestDate Wed Jul 02 05:03:32 EDT 2025
Mon Jul 21 05:56:52 EDT 2025
Thu Jul 31 00:01:55 EDT 2025
Sat Aug 30 17:17:42 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords Breast cancer resistance protein (BCRP)
Mutation
Coupling helix
Polymorphism
Language English
License This is an open access article under the CC BY license.
Copyright © 2025 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c419t-9e3e95c548242e3c70b1946dcefddf07fd187bce1fd6232b738980738557915e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-6960-7757
0000-0003-1163-0182
0000-0002-3225-9186
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S134743672500432X
PMID 40203631
PQID 3188427999
PQPubID 23479
ParticipantIDs proquest_miscellaneous_3188427999
pubmed_primary_40203631
crossref_primary_10_1016_j_dmpk_2025_101482
elsevier_sciencedirect_doi_10_1016_j_dmpk_2025_101482
PublicationCentury 2000
PublicationDate 2025-06-01
PublicationDateYYYYMMDD 2025-06-01
PublicationDate_xml – month: 06
  year: 2025
  text: 2025-06-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Drug metabolism and pharmacokinetics
PublicationTitleAlternate Drug Metab Pharmacokinet
PublicationYear 2025
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References Manolaridis, Jackson, Taylor, Kowal, Stahlberg, Locher (bib11) 2018; 563
Lee, O'Connor, Ritchie, Galetin, Cook, Ragueneau-Majlessi (bib2) 2015; 43
Furukawa, Wakabayashi, Tamura, Nakagawa, Morishima, Osawa (bib9) 2009; 26
Taylor, Manolaridis, Jackson, Kowal, Stahlberg, Locher (bib6) 2017; 546
Tanaka, Kitamura, Maeda, Sugiyama (bib29) 2015; 104
Bauer, Römermann, Karch, Wulkersdorfer, Stanek, Philippe (bib3) 2016; 100
Dankers, Sweep, Pertijs, Verweij, van den Heuvel, Koenderink (bib13) 2012; 349
Mizuarai, Aozasa, Kotani (bib24) 2004; 109
Woodward, Tukaye, Cui, Greenwell, Constantoulakis, Parker (bib10) 2013; 110
Tamura, Onishi, An, Koshiba, Wakabayashi, Hoshijima (bib23) 2007; 22
Morisaki, Robey, Özvegy-Laczka, Honjo, Polgar, Steadman (bib22) 2005; 56
Cai, Bikadi, Ni, Lee, Wang, Rosenberg (bib31) 2010; 333
Adzhubei, Schmidt, Peshkin, Ramensky, Gerasimova, Bork (bib33) 2010; 7
Mao, Unadkat (bib1) 2015; 17
Bircsak, Moscovitz, Wen, Archer, Yuen, Mohammed (bib26) 2018; 46
Prasad, Lai, Lin, Unadkat (bib27) 2013; 102
Ingelman-Sundberg, Mkrtchian, Zhou, Lauschke (bib19) 2018; 12
Clark, Kerr, Callaghan (bib7) 2006; 149
Sim, Kumar, Hu, Henikoff, Schneider, Ng (bib32) 2012; 40
Sjöstedt, van den Heuvel, Koenderink, Kidron (bib14) 2017; 34
Giacomini, Balimane, Cho, Eadon, Edeki, Hillgren (bib18) 2013; 94
Khunweeraphong, Stockner, Kuchler (bib12) 2017; 7
Wan, Wang, Li, Xu, Pei, Peng (bib25) 2015; 354
Gardner, Ahlers, Shukla, Sissung, Ockers, Price (bib28) 2008; 102
Fairley, Lowy-Gallego, Perry, Flicek (bib20) 2020; 48
Puris, Auriola, Korhonen, Loppi, Kanninen, Malm (bib17) 2021; 110
Niemi (bib5) 2010; 87
Higashino, Takada, Nakaoka, Toyoda, Stiburkova, Miyata (bib30) 2017; 3
Cox, Kapoor, Briggs, Kerr (bib8) 2018; 475
Heyes, Kapoor, Kerr (bib4) 2018; 46
Uchida, Tachikawa, Obuchi, Hoshi, Tomioka, Ohtsuki (bib16) 2013; 10
Kondo, Suzuki, Itoda, Ozawa, Sawada, Kobayashi (bib21) 2004; 21
Kiander, Vellonen, Malinen, Gynther, Hagström, Bhattacharya (bib15) 2021; 38
Wan (10.1016/j.dmpk.2025.101482_bib25) 2015; 354
Cox (10.1016/j.dmpk.2025.101482_bib8) 2018; 475
Heyes (10.1016/j.dmpk.2025.101482_bib4) 2018; 46
Clark (10.1016/j.dmpk.2025.101482_bib7) 2006; 149
Sjöstedt (10.1016/j.dmpk.2025.101482_bib14) 2017; 34
Bauer (10.1016/j.dmpk.2025.101482_bib3) 2016; 100
Manolaridis (10.1016/j.dmpk.2025.101482_bib11) 2018; 563
Ingelman-Sundberg (10.1016/j.dmpk.2025.101482_bib19) 2018; 12
Morisaki (10.1016/j.dmpk.2025.101482_bib22) 2005; 56
Mizuarai (10.1016/j.dmpk.2025.101482_bib24) 2004; 109
Higashino (10.1016/j.dmpk.2025.101482_bib30) 2017; 3
Woodward (10.1016/j.dmpk.2025.101482_bib10) 2013; 110
Fairley (10.1016/j.dmpk.2025.101482_bib20) 2020; 48
Kondo (10.1016/j.dmpk.2025.101482_bib21) 2004; 21
Furukawa (10.1016/j.dmpk.2025.101482_bib9) 2009; 26
Khunweeraphong (10.1016/j.dmpk.2025.101482_bib12) 2017; 7
Adzhubei (10.1016/j.dmpk.2025.101482_bib33) 2010; 7
Tamura (10.1016/j.dmpk.2025.101482_bib23) 2007; 22
Tanaka (10.1016/j.dmpk.2025.101482_bib29) 2015; 104
Kiander (10.1016/j.dmpk.2025.101482_bib15) 2021; 38
Mao (10.1016/j.dmpk.2025.101482_bib1) 2015; 17
Uchida (10.1016/j.dmpk.2025.101482_bib16) 2013; 10
Gardner (10.1016/j.dmpk.2025.101482_bib28) 2008; 102
Prasad (10.1016/j.dmpk.2025.101482_bib27) 2013; 102
Sim (10.1016/j.dmpk.2025.101482_bib32) 2012; 40
Taylor (10.1016/j.dmpk.2025.101482_bib6) 2017; 546
Dankers (10.1016/j.dmpk.2025.101482_bib13) 2012; 349
Bircsak (10.1016/j.dmpk.2025.101482_bib26) 2018; 46
Niemi (10.1016/j.dmpk.2025.101482_bib5) 2010; 87
Cai (10.1016/j.dmpk.2025.101482_bib31) 2010; 333
Lee (10.1016/j.dmpk.2025.101482_bib2) 2015; 43
Giacomini (10.1016/j.dmpk.2025.101482_bib18) 2013; 94
Puris (10.1016/j.dmpk.2025.101482_bib17) 2021; 110
References_xml – volume: 34
  start-page: 1626
  year: 2017
  end-page: 1636
  ident: bib14
  article-title: Transmembrane domain single-nucleotide polymorphisms impair expression and transport activity of ABC transporter ABCG2
  publication-title: Pharm Res
– volume: 3
  year: 2017
  ident: bib30
  article-title: Multiple common and rare variants of ABCG2 cause gout
  publication-title: RMD Open
– volume: 475
  start-page: 1553
  year: 2018
  end-page: 1567
  ident: bib8
  article-title: Residues contributing to drug transport by ABCG2 are localised to multiple drug-binding pockets
  publication-title: Biochem J
– volume: 94
  start-page: 23
  year: 2013
  end-page: 26
  ident: bib18
  article-title: International transporter consortium commentary on clinically important transporter polymorphisms
  publication-title: Clin Pharmacol Ther
– volume: 38
  start-page: 1663
  year: 2021
  end-page: 1675
  ident: bib15
  article-title: The effect of single nucleotide variations in the transmembrane domain of OATP1B1 on in vitro functionality
  publication-title: Pharm Res
– volume: 21
  start-page: 1895
  year: 2004
  end-page: 1903
  ident: bib21
  article-title: Functional analysis of SNPs variants of BCRP/ABCG2
  publication-title: Pharm Res
– volume: 102
  start-page: 1694
  year: 2008
  end-page: 1699
  ident: bib28
  article-title: Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival
  publication-title: BJU Int
– volume: 110
  start-page: 3953
  year: 2021
  end-page: 3962
  ident: bib17
  article-title: Systemic inflammation induced changes in protein expression of ABC transporters and ionotropic glutamate receptor subunit 1 in the cerebral cortex of familial Alzheimer's disease mouse model
  publication-title: J Pharm Sci
– volume: 40
  start-page: W452
  year: 2012
  end-page: W457
  ident: bib32
  article-title: SIFT web server: predicting effects of amino acid substitutions on proteins
  publication-title: Nucleic Acids Res
– volume: 46
  start-page: 1886
  year: 2018
  end-page: 1899
  ident: bib4
  article-title: Polymorphisms of the multidrug pump ABCG2: a systematic review of their effect on protein expression, function, and drug pharmacokinetics
  publication-title: Drug Metab Dispos
– volume: 349
  start-page: 551
  year: 2012
  end-page: 563
  ident: bib13
  article-title: Localization of breast cancer resistance protein (Bcrp) in endocrine organs and inhibition of its transport activity by steroid hormones
  publication-title: Cell Tissue Res
– volume: 17
  start-page: 65
  year: 2015
  end-page: 82
  ident: bib1
  article-title: Role of the breast cancer resistance protein (BCRP/ABCG2) in drug transport--an update
  publication-title: AAPS J
– volume: 149
  start-page: 506
  year: 2006
  end-page: 515
  ident: bib7
  article-title: Multiple drugbinding sites on the R482G isoform of the ABCG2 transporter
  publication-title: Br J Pharmacol
– volume: 12
  start-page: 26
  year: 2018
  ident: bib19
  article-title: Integrating rare genetic variants into pharmacogenetic drug response predictions
  publication-title: Hum Genom
– volume: 7
  year: 2017
  ident: bib12
  article-title: The structure of the human ABC transporter ABCG2 reveals a novel mechanism for drug extrusion
  publication-title: Sci Rep
– volume: 563
  start-page: 426
  year: 2018
  end-page: 430
  ident: bib11
  article-title: Cryo-EM structures of a human ABCG2 mutant trapped in ATP-bound and substrate-bound states
  publication-title: Nature
– volume: 354
  start-page: 310
  year: 2015
  end-page: 315
  ident: bib25
  article-title: Marked alteration of rosuvastatin pharmacokinetics in healthy Chinese with ABCG2 34G>A and 421C>A homozygote or compound heterozygote
  publication-title: J Pharmacol Exp Ther
– volume: 104
  start-page: 3039
  year: 2015
  end-page: 3048
  ident: bib29
  article-title: Quantitative analysis of the ABCG2 c.421C>A polymorphism effect on in vivo transport activity of breast cancer resistance protein (BCRP) using an intestinal absorption model
  publication-title: J Pharm Sci
– volume: 87
  start-page: 130
  year: 2010
  end-page: 133
  ident: bib5
  article-title: Transporter pharmacogenetics and statin toxicity
  publication-title: Clin Pharmacol Ther
– volume: 26
  start-page: 469
  year: 2009
  end-page: 479
  ident: bib9
  article-title: Major SNP (Q141K) variant of human ABC transporter ABCG2 undergoes lysosomal and proteasomal degradations
  publication-title: Pharm Res
– volume: 22
  start-page: 428
  year: 2007
  end-page: 440
  ident: bib23
  article-title: In vitro evaluation of photosensitivity risk related to genetic polymorphisms of human ABC transporter ABCG2 and inhibition by drugs
  publication-title: Drug Metabol Pharmacokinet
– volume: 48
  start-page: D941
  year: 2020
  end-page: D947
  ident: bib20
  article-title: The International Genome Sample Resource (IGSR) collection of open human genomic variation resources
  publication-title: Nucleic Acids Res
– volume: 333
  start-page: 670
  year: 2010
  end-page: 681
  ident: bib31
  article-title: Role of basic residues within or near the predicted transmembrane helix 2 of the human breast cancer resistance protein in drug transport
  publication-title: J Pharmacol Exp Ther
– volume: 102
  start-page: 787
  year: 2013
  end-page: 793
  ident: bib27
  article-title: Interindividual variability in the hepatic expression of the human breast cancer resistance protein (BCRP/ABCG2): effect of age, sex, and genotype
  publication-title: J Pharm Sci
– volume: 110
  start-page: 5223
  year: 2013
  end-page: 5228
  ident: bib10
  article-title: Gout-causing Q141K mutation in ABCG2 leads to instability of the nucleotide-binding domain and can be corrected with small molecules
  publication-title: Proc Natl Acad Sci U S A
– volume: 10
  start-page: 21
  year: 2013
  ident: bib16
  article-title: A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood-brain barrier in ddY, FVB, and C57BL/6J mice
  publication-title: Fluids Barriers CNS
– volume: 546
  start-page: 504
  year: 2017
  end-page: 509
  ident: bib6
  article-title: Structure of the human multidrug transporter ABCG2
  publication-title: Nature
– volume: 46
  start-page: 619
  year: 2018
  end-page: 627
  ident: bib26
  article-title: Interindividual regulation of the breast cancer resistance protein/ABCG2 transporter in term human placentas
  publication-title: Drug Metab Dispos
– volume: 7
  start-page: 248
  year: 2010
  end-page: 249
  ident: bib33
  article-title: A method and server for predicting damaging missense mutations
  publication-title: Nat Methods
– volume: 43
  start-page: 490
  year: 2015
  end-page: 509
  ident: bib2
  article-title: Breast cancer resistance protein (ABCG2) in clinical pharmacokinetics and drug interactions: practical recommendations for clinical victim and perpetrator drug-drug interaction study design
  publication-title: Drug Metab Dispos
– volume: 100
  start-page: 131
  year: 2016
  end-page: 141
  ident: bib3
  article-title: Pilot PET study to assess the functional interplay between ABCB1 and ABCG2 at the human blood–brain barrier
  publication-title: Clin Pharmacol Ther
– volume: 109
  start-page: 238
  year: 2004
  end-page: 246
  ident: bib24
  article-title: Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2
  publication-title: Int J Cancer
– volume: 56
  start-page: 161
  year: 2005
  end-page: 172
  ident: bib22
  article-title: Single nucleotide polymorphisms modify the transporter activity of ABCG2
  publication-title: Cancer Chemother Pharmacol
– volume: 349
  start-page: 551
  year: 2012
  ident: 10.1016/j.dmpk.2025.101482_bib13
  article-title: Localization of breast cancer resistance protein (Bcrp) in endocrine organs and inhibition of its transport activity by steroid hormones
  publication-title: Cell Tissue Res
  doi: 10.1007/s00441-012-1417-5
– volume: 475
  start-page: 1553
  year: 2018
  ident: 10.1016/j.dmpk.2025.101482_bib8
  article-title: Residues contributing to drug transport by ABCG2 are localised to multiple drug-binding pockets
  publication-title: Biochem J
  doi: 10.1042/BCJ20170923
– volume: 34
  start-page: 1626
  year: 2017
  ident: 10.1016/j.dmpk.2025.101482_bib14
  article-title: Transmembrane domain single-nucleotide polymorphisms impair expression and transport activity of ABC transporter ABCG2
  publication-title: Pharm Res
  doi: 10.1007/s11095-017-2127-1
– volume: 38
  start-page: 1663
  year: 2021
  ident: 10.1016/j.dmpk.2025.101482_bib15
  article-title: The effect of single nucleotide variations in the transmembrane domain of OATP1B1 on in vitro functionality
  publication-title: Pharm Res
  doi: 10.1007/s11095-021-03107-8
– volume: 110
  start-page: 3953
  year: 2021
  ident: 10.1016/j.dmpk.2025.101482_bib17
  article-title: Systemic inflammation induced changes in protein expression of ABC transporters and ionotropic glutamate receptor subunit 1 in the cerebral cortex of familial Alzheimer's disease mouse model
  publication-title: J Pharm Sci
  doi: 10.1016/j.xphs.2021.08.013
– volume: 104
  start-page: 3039
  year: 2015
  ident: 10.1016/j.dmpk.2025.101482_bib29
  article-title: Quantitative analysis of the ABCG2 c.421C>A polymorphism effect on in vivo transport activity of breast cancer resistance protein (BCRP) using an intestinal absorption model
  publication-title: J Pharm Sci
  doi: 10.1002/jps.24366
– volume: 48
  start-page: D941
  year: 2020
  ident: 10.1016/j.dmpk.2025.101482_bib20
  article-title: The International Genome Sample Resource (IGSR) collection of open human genomic variation resources
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkz836
– volume: 563
  start-page: 426
  year: 2018
  ident: 10.1016/j.dmpk.2025.101482_bib11
  article-title: Cryo-EM structures of a human ABCG2 mutant trapped in ATP-bound and substrate-bound states
  publication-title: Nature
  doi: 10.1038/s41586-018-0680-3
– volume: 102
  start-page: 1694
  year: 2008
  ident: 10.1016/j.dmpk.2025.101482_bib28
  article-title: Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival
  publication-title: BJU Int
  doi: 10.1111/j.1464-410X.2008.07913.x
– volume: 94
  start-page: 23
  year: 2013
  ident: 10.1016/j.dmpk.2025.101482_bib18
  article-title: International transporter consortium commentary on clinically important transporter polymorphisms
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2013.12
– volume: 56
  start-page: 161
  year: 2005
  ident: 10.1016/j.dmpk.2025.101482_bib22
  article-title: Single nucleotide polymorphisms modify the transporter activity of ABCG2
  publication-title: Cancer Chemother Pharmacol
  doi: 10.1007/s00280-004-0931-x
– volume: 22
  start-page: 428
  year: 2007
  ident: 10.1016/j.dmpk.2025.101482_bib23
  article-title: In vitro evaluation of photosensitivity risk related to genetic polymorphisms of human ABC transporter ABCG2 and inhibition by drugs
  publication-title: Drug Metabol Pharmacokinet
  doi: 10.2133/dmpk.22.428
– volume: 10
  start-page: 21
  year: 2013
  ident: 10.1016/j.dmpk.2025.101482_bib16
  publication-title: Fluids Barriers CNS
  doi: 10.1186/2045-8118-10-21
– volume: 40
  start-page: W452
  year: 2012
  ident: 10.1016/j.dmpk.2025.101482_bib32
  article-title: SIFT web server: predicting effects of amino acid substitutions on proteins
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gks539
– volume: 102
  start-page: 787
  year: 2013
  ident: 10.1016/j.dmpk.2025.101482_bib27
  article-title: Interindividual variability in the hepatic expression of the human breast cancer resistance protein (BCRP/ABCG2): effect of age, sex, and genotype
  publication-title: J Pharm Sci
  doi: 10.1002/jps.23436
– volume: 3
  year: 2017
  ident: 10.1016/j.dmpk.2025.101482_bib30
  article-title: Multiple common and rare variants of ABCG2 cause gout
  publication-title: RMD Open
  doi: 10.1136/rmdopen-2017-000464
– volume: 109
  start-page: 238
  year: 2004
  ident: 10.1016/j.dmpk.2025.101482_bib24
  article-title: Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2
  publication-title: Int J Cancer
  doi: 10.1002/ijc.11669
– volume: 21
  start-page: 1895
  year: 2004
  ident: 10.1016/j.dmpk.2025.101482_bib21
  article-title: Functional analysis of SNPs variants of BCRP/ABCG2
  publication-title: Pharm Res
  doi: 10.1023/B:PHAM.0000045245.21637.d4
– volume: 100
  start-page: 131
  year: 2016
  ident: 10.1016/j.dmpk.2025.101482_bib3
  article-title: Pilot PET study to assess the functional interplay between ABCB1 and ABCG2 at the human blood–brain barrier
  publication-title: Clin Pharmacol Ther
  doi: 10.1002/cpt.362
– volume: 333
  start-page: 670
  year: 2010
  ident: 10.1016/j.dmpk.2025.101482_bib31
  article-title: Role of basic residues within or near the predicted transmembrane helix 2 of the human breast cancer resistance protein in drug transport
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.109.163493
– volume: 46
  start-page: 1886
  year: 2018
  ident: 10.1016/j.dmpk.2025.101482_bib4
  article-title: Polymorphisms of the multidrug pump ABCG2: a systematic review of their effect on protein expression, function, and drug pharmacokinetics
  publication-title: Drug Metab Dispos
  doi: 10.1124/dmd.118.083030
– volume: 110
  start-page: 5223
  year: 2013
  ident: 10.1016/j.dmpk.2025.101482_bib10
  article-title: Gout-causing Q141K mutation in ABCG2 leads to instability of the nucleotide-binding domain and can be corrected with small molecules
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1214530110
– volume: 12
  start-page: 26
  year: 2018
  ident: 10.1016/j.dmpk.2025.101482_bib19
  article-title: Integrating rare genetic variants into pharmacogenetic drug response predictions
  publication-title: Hum Genom
  doi: 10.1186/s40246-018-0157-3
– volume: 87
  start-page: 130
  year: 2010
  ident: 10.1016/j.dmpk.2025.101482_bib5
  article-title: Transporter pharmacogenetics and statin toxicity
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2009.197
– volume: 7
  year: 2017
  ident: 10.1016/j.dmpk.2025.101482_bib12
  article-title: The structure of the human ABC transporter ABCG2 reveals a novel mechanism for drug extrusion
  publication-title: Sci Rep
  doi: 10.1038/s41598-017-11794-w
– volume: 43
  start-page: 490
  year: 2015
  ident: 10.1016/j.dmpk.2025.101482_bib2
  article-title: Breast cancer resistance protein (ABCG2) in clinical pharmacokinetics and drug interactions: practical recommendations for clinical victim and perpetrator drug-drug interaction study design
  publication-title: Drug Metab Dispos
  doi: 10.1124/dmd.114.062174
– volume: 17
  start-page: 65
  year: 2015
  ident: 10.1016/j.dmpk.2025.101482_bib1
  article-title: Role of the breast cancer resistance protein (BCRP/ABCG2) in drug transport--an update
  publication-title: AAPS J
  doi: 10.1208/s12248-014-9668-6
– volume: 149
  start-page: 506
  year: 2006
  ident: 10.1016/j.dmpk.2025.101482_bib7
  article-title: Multiple drugbinding sites on the R482G isoform of the ABCG2 transporter
  publication-title: Br J Pharmacol
  doi: 10.1038/sj.bjp.0706904
– volume: 354
  start-page: 310
  year: 2015
  ident: 10.1016/j.dmpk.2025.101482_bib25
  article-title: Marked alteration of rosuvastatin pharmacokinetics in healthy Chinese with ABCG2 34G>A and 421C>A homozygote or compound heterozygote
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.115.225045
– volume: 7
  start-page: 248
  year: 2010
  ident: 10.1016/j.dmpk.2025.101482_bib33
  article-title: A method and server for predicting damaging missense mutations
  publication-title: Nat Methods
  doi: 10.1038/nmeth0410-248
– volume: 46
  start-page: 619
  year: 2018
  ident: 10.1016/j.dmpk.2025.101482_bib26
  article-title: Interindividual regulation of the breast cancer resistance protein/ABCG2 transporter in term human placentas
  publication-title: Drug Metab Dispos
  doi: 10.1124/dmd.117.079228
– volume: 26
  start-page: 469
  year: 2009
  ident: 10.1016/j.dmpk.2025.101482_bib9
  article-title: Major SNP (Q141K) variant of human ABC transporter ABCG2 undergoes lysosomal and proteasomal degradations
  publication-title: Pharm Res
  doi: 10.1007/s11095-008-9752-7
– volume: 546
  start-page: 504
  year: 2017
  ident: 10.1016/j.dmpk.2025.101482_bib6
  article-title: Structure of the human multidrug transporter ABCG2
  publication-title: Nature
  doi: 10.1038/nature22345
SSID ssj0033542
Score 2.4032025
Snippet ABCG2 (breast cancer resistance protein, BCRP), can affect drug disposition, and thus, variation in the ABCG2 gene may alter drug exposure. We studied...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 101482
SubjectTerms ATP Binding Cassette Transporter, Subfamily G, Member 2 - chemistry
ATP Binding Cassette Transporter, Subfamily G, Member 2 - genetics
ATP Binding Cassette Transporter, Subfamily G, Member 2 - metabolism
Biological Transport - genetics
Breast cancer resistance protein (BCRP)
Coupling helix
Estrone - analogs & derivatives
Estrone - metabolism
Genetic Variation - genetics
HEK293 Cells
Humans
Mutation
Neoplasm Proteins - chemistry
Neoplasm Proteins - genetics
Neoplasm Proteins - metabolism
Polymorphism
Polymorphism, Single Nucleotide - genetics
Rosuvastatin Calcium - metabolism
Title Exploring the effect of intracellular loop 1 genetic variants in human ABCG2 on transport activity and protein abundance
URI https://dx.doi.org/10.1016/j.dmpk.2025.101482
https://www.ncbi.nlm.nih.gov/pubmed/40203631
https://www.proquest.com/docview/3188427999
Volume 62
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELba7YUL4s0CrQYJ9UKjXcd24hy3K9oFRFWJVtqbFb-kLZCs6Ba1_74zcdKKQzlwjDVWohl7Zux83wxjH3DvaadizKwuXCaDUJkuVJm54B0a3EYfie_87aRYnMsvS7XcYvOBC0Owyt73J5_eeet-ZNJrc7JerSbfiQQpRVFiEKe6cstttpOLqtAjtjP7_HVxMjhkIVTXQ4fkM5rQc2cSzMv_Wv_AY2KuaEDq_KH49FD-2cWhoyfscZ9Awix941O2FZpnbP80VaC-OYCze0LV5QHsw-l9beqb5-z6DnMHmPlBQnNAG2FFl7x0i0-wVPjZtmvggIuLOI7wBw_UhJdBKeia-sHscH6cQ9vAZiiODsSQoEYUUDceuvIPKF1bYpqgUl-w86NPZ_NF1jdfyJzk1SarggiVcnigwSAehCunlley8C5E7-O0jJ7r0rrAo8cMKrclZj56SrVxVFlxFcRLNmraJrxmwLlTdDVcWhmlk3ktVK1RxMbKWaf0mH0cVG7WqcaGGcBnF4YMZMhAJhlozNRgFfPXSjEYBP457_1gQoNbiDRaN6G9ujTo1rTMS0yVx-xVsu3dd8juT63gb_7zrW_ZI3pK4LJ3bLT5fRV2MY3Z2L1-me6x7eMlvwVQlfKh
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbK9gAX1PLqUgqDhHqh0W4SO3aOy4qype2qEltpb1b8kpZHsqJbRP89M3HSikM5cHXGSjRjz4yd75th7B3uPWVFCIlRhU24z0WiCiET651Fg5vgAvGdz-fF7JJ_XorlFpv2XBiCVXa-P_r01lt3I6NOm6P1ajX6QiRInhcSgzjVlVs-YNtUnYoP2Pbk5HQ27x1ynou2hw7JJzSh485EmJf7sf6Gx8RM0ABX2X3x6b78s41DxzvscZdAwiR-4y7b8vUTdngRK1DfHMHijlB1dQSHcHFXm_rmKft9i7kDzPwgojmgCbCiS166xSdYKnxvmjWkgIuLOI7wCw_UhJdBKWib-sHkw_RTBk0Nm744OhBDghpRQFU7aMs_oHRliGmCSn3GLo8_LqazpGu-kFielpuk9LkvhcUDDQZxn1s5NmnJC2d9cC6MZXCpksb6NDjMoDIjMfNRY6qNI2SZCp8_Z4O6qf0egzS1gq6GpeGBW55VuagUiphQWmOFGrL3vcr1OtbY0D347KsmA2kykI4GGjLRW0X_tVI0BoF_znvbm1DjFiKNVrVvrq80ujXFM4mp8pC9iLa9_Q7e_qnN05f_-dY37OFscX6mz07mp_vsET2JQLNXbLD5ee0PMKXZmNfdkv0DDYj0lg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exploring+the+effect+of+intracellular+loop+1+genetic+variants+in+human+ABCG2+on+transport+activity+and+protein+abundance&rft.jtitle=Drug+metabolism+and+pharmacokinetics&rft.au=Sj%C3%B6stedt%2C+Noora&rft.au=Timmermans%2C+Ritchie+G.M.&rft.au=Vieraankivi%2C+Marika&rft.au=Suominen%2C+Laura&rft.date=2025-06-01&rft.issn=1347-4367&rft.volume=62&rft.spage=101482&rft_id=info:doi/10.1016%2Fj.dmpk.2025.101482&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_dmpk_2025_101482
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1347-4367&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1347-4367&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1347-4367&client=summon